EFFECTS OF SMALL-SIDED GAME MANIPULATIONS ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL RESPONSES, PHYSICAL PERFORMANCE, AND TECHNICAL SKILLS IN FEMALE FOOTBALL PLAYERS
THE EFFECT OF MANIPULATIONS APPLIED IN SMALL-SIDED GAMES ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL, PHYSICAL AND TECHNICAL PARAMETERS IN FEMALE FOOTBALLERS
Small-sided games will represent a prevalent component of branch-specific training methodologies in football. The objective of this study will be to examine the impact of small-sided games with sprint manipulation played in a 3v3 configuration on neuromuscular fatigue, along with physical, physiological, and technical parameters, in female football players.
The study will be conducted on a group of 12 female football players (experimental: 6, control: 6) who will have been actively playing licensed football for a minimum of three years. The participants will be asked to record their performance data over a six-week period, during which their physiological and physical parameters will be measured using Catapult (GPS) systems. The degree of neuromuscular fatigue will be determined through the active vertical jump test.
The data obtained from the study will be analysed using a Repeated Measures ANOVA test, with the significance level set at p < 0.05. Data analysis will be performed using the JASP 0.19.2 software package. It is expected that the results will reveal statistically significant differences in physiological parameters such as player load and perceived exertion level. In physical parameters, statistically significant differences are anticipated in total distance, positive acceleration, vertical jump performance, and running speed zones 1-2-3-4 (p < 0.05).
Consequently, the present study will aim to demonstrate that coaches may utilise this information in the organisation of training programmes to enhance performance parameters such as total distance covered, positive acceleration, and velocity, while simultaneously reducing neuromuscular fatigue in female football players.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Istanbul, Türkei (türkiye)
- İstanbul Gelişim Üniversitesi
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Participants must be between the ages of 18 and 25. Participants must have played football at least three times. Participants must not have any health issues. Participants must voluntarily take part in the study.
Exclusion Criteria:
Participants not being between the ages of 18 and 25. Participants not having played licensed football for at least three years. Participants having a health issue.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Arm 1 (Experimental)
Sprint |
In the study, the experimental group was exposed to sprint manipulation, unlike the control group. |
|
Sonstiges: Arm 2 (Control)
In the study, unlike the experimental group, the control group was given a 10-second recovery period. |
In the study, unlike the experimental group, the control group was given a 10-second recovery period. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Neuromuscular Fatigue (Active Vertical Jump Height)
Zeitfenster: Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)
|
Neuromuscular fatigue was assessed using the Active Vertical Jump Test (AVJT). Jump height was recorded in centimeters (cm) using a ForceDecks force platform. Each participant performed three trials with a two-minute rest between attempts, following a standardized warm-up protocol. |
Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Perceived Exertion Level
Zeitfenster: Baseline, Week 3, and Week 6
|
Perceived exertion was assessed using the Borg CR-10 Perceived Exertion Scale, scored from 1 (lowest) to 10 (highest), recorded 30 minutes after each training session. |
Baseline, Week 3, and Week 6
|
|
Change in Maximum Heart Rate
Zeitfenster: Baseline, Week 3, and Week 6
|
Maximum heart rate was recorded using the Polar Team Pro GPS system, expressed in beats per minute (bpm). |
Baseline, Week 3, and Week 6
|
|
Change in Estimated Maximal Oxygen Uptake (VO2max)
Zeitfenster: Baseline, Week 3, and Week 6
|
Aerobic capacity was estimated using the 30-15 Intermittent Fitness Test (Buchheit formula), expressed in ml/kg/min. |
Baseline, Week 3, and Week 6
|
|
Change in Positive Acceleration
Zeitfenster: Baseline, Week 3, and Week 6
|
Positive acceleration was recorded using the Polar Team Pro GPS system, expressed in meters per second squared (m/s²). |
Baseline, Week 3, and Week 6
|
|
Change in Sprint Distance
Zeitfenster: Baseline, Week 3, and Week 6
|
Sprint distance was recorded using the Polar Team Pro GPS system, expressed in meters (m). |
Baseline, Week 3, and Week 6
|
|
Change in Distance Covered per Running Speed Zone
Zeitfenster: Baseline, Week 3, and Week 6
|
Distance covered was categorized into five speed zones using the Polar Team Pro GPS system: Zone 1 (0-6 km/h), Zone 2 (6.1-12 km/h), Zone 3 (12.1-15.4 km/h), Zone 4 (15.5-18.3 km/h), and Zone 5 (>18.4 km/h), expressed in meters (m). |
Baseline, Week 3, and Week 6
|
|
Change in Player Load
Zeitfenster: Baseline, Week 3, and Week 6
|
Player load, a composite measure of physical demand, was recorded using the Polar Team Pro GPS tracking system, expressed in arbitrary units (AU). |
Baseline, Week 3, and Week 6
|
|
Change in Total Distance Covered
Zeitfenster: Baseline, Week 3, and Week 6
|
Total distance covered during small-sided games was recorded using the Polar Team Pro GPS system, expressed in meters (m). |
Baseline, Week 3, and Week 6
|
|
Change in Technical Performance Parameters
Zeitfenster: Baseline, Week 3, and Week 6
|
Technical performance (accurate passes, inaccurate passes, dribbles, one-on-one battles, feints, and ball losses) was recorded via video analysis (GoPro Hero 12 Black) using computerized notational coding, expressed as count of actions. |
Baseline, Week 3, and Week 6
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 2024-01-107
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .